Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 436 of 1,261
  1. US 10588911

    Compositions comprising triterpenoids

    REGENERA PHARMA LTD. · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  2. US 10588982

    Site-specific covalent chemical ligation to monoclonal and polyclonal immunoglobulin

    The Regents of the University of California · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  3. US 10588949

    Factor IX polypeptide formulations

    BIOVERATIV THERAPEUTICS INC. · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  4. US 10590137

    Mercaptopurine hemihydrate

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  5. US 10588907

    Methods and compositions for inhibiting the interaction of menin with MLL proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  6. US 10588983

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  7. US 10588897

    Piericidin bacterial inhibitors

    The Regents of the University of California · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  8. US 10588984

    Virus-like particle conjugates for diagnosis and treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  9. US 10588936

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  10. US 10590093

    1,2,4-oxadiazole derivatives as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  11. US 10588943

    Glucokinase activator compositions for the treatment of diabetes

    VTV THERAPEUTICS LLC · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  12. US 10588878

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  13. US 10588867

    Modulating antibacterial immunity via bacterial membrane-coated nanoparticles

    The Regents of the University of California · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  14. US 10591468

    Circulating antibodies against MAA adducts as biomarker for coronary artery disease

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  15. US 10590127

    P2X3 and/or P2X2/3 compounds and methods

    Asana BioSciences, LLC · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  16. US 10588940

    Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  17. US 10583134

    Methods and therapeutic combinations for treating tumors

    The Board of Regents of the University of Texas · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  18. US 10583145

    Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

    The Board of Regents of the University of Texas System · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  19. US 10582707

    Antimicrobial antibacterial and spore germination inhibiting activity from an avocado extract enriched in bioactive compounds

    INSTITUTO TECNOLÓGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  20. US 10584355

    Chimpanzee adenoviral vector-based filovirus vaccines

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  21. US 10584115

    Substituted pyridine and pyrazine BMI-1 inhibitors

    PTC THERAPEUTICS, INC. · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  22. US 10583186

    Compositions comprising recombinant probiotic bacteria and methods of use thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  23. US 10583200

    Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  24. US 10582702

    Non-human animals having an engineered ANGPTL8 gene

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.